Frances Daley

4.6k total citations
52 papers, 2.3k citations indexed

About

Frances Daley is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Frances Daley has authored 52 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 20 papers in Cancer Research and 17 papers in Molecular Biology. Recurrent topics in Frances Daley's work include Cancer, Hypoxia, and Metabolism (8 papers), Cancer Cells and Metastasis (7 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Frances Daley is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Cancer Cells and Metastasis (7 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Frances Daley collaborates with scholars based in United Kingdom, United States and Canada. Frances Daley's co-authors include George D. Wilson, Søren M. Bentzen, Michele I. Saunders, Peter Hoskin, Stanley Dische, Paul Richman, Amen Sibtain, P I Richman, Adrian L. Harris and Dawn Carnell and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Frances Daley

51 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frances Daley United Kingdom 27 934 886 759 539 528 52 2.3k
Nicholas H. A. Terry United States 28 455 0.5× 854 1.0× 647 0.9× 559 1.0× 450 0.9× 90 2.3k
Ruth Heimann United States 25 1.1k 1.1× 908 1.0× 970 1.3× 684 1.3× 260 0.5× 69 2.8k
Kristian Unger Germany 31 935 1.0× 1.6k 1.7× 667 0.9× 446 0.8× 331 0.6× 101 2.9k
Sean P. Pitroda United States 33 677 0.7× 1.1k 1.3× 1.8k 2.3× 1.0k 1.9× 485 0.9× 94 3.4k
N. Chavaudra France 21 664 0.7× 565 0.6× 590 0.8× 458 0.8× 564 1.1× 38 1.7k
Paul Frankel United States 34 658 0.7× 1.8k 2.0× 1.9k 2.6× 967 1.8× 404 0.8× 214 4.1k
Timothy D. Shafman United States 25 324 0.3× 1.1k 1.2× 660 0.9× 884 1.6× 780 1.5× 69 2.6k
Reinhard von Roemeling United States 23 606 0.6× 774 0.9× 728 1.0× 626 1.2× 131 0.2× 72 2.0k
Viswam S. Nair United States 21 781 0.8× 1.1k 1.2× 1.5k 2.0× 1.1k 2.1× 466 0.9× 44 3.4k
Shyhmin Huang United States 23 291 0.3× 1.1k 1.2× 1.5k 2.0× 1.0k 1.9× 380 0.7× 39 2.4k

Countries citing papers authored by Frances Daley

Since Specialization
Citations

This map shows the geographic impact of Frances Daley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances Daley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances Daley more than expected).

Fields of papers citing papers by Frances Daley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances Daley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances Daley. The network helps show where Frances Daley may publish in the future.

Co-authorship network of co-authors of Frances Daley

This figure shows the co-authorship network connecting the top 25 collaborators of Frances Daley. A scholar is included among the top collaborators of Frances Daley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frances Daley. Frances Daley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wilkins, Anna, Barry A. Gusterson, Holly Tovey, et al.. (2023). Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation. EBioMedicine. 88. 104436–104436. 5 indexed citations
3.
Naidoo, Kuban D., Patty T. Wai, Sarah Maguire, et al.. (2018). Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast Cancer. Molecular Cancer Therapeutics. 17(1). 306–315. 54 indexed citations
4.
Wilkins, Anna, Ritika Chauhan, Alistair G. Rust, et al.. (2018). FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment. Breast Cancer Research and Treatment. 170(3). 573–581. 4 indexed citations
5.
Wai, Patty T., Philip Bland, Saira Khalique, et al.. (2016). Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures. Journal of Visualized Experiments. 15 indexed citations
6.
Maguire, Sarah, Barrie Peck, Patty T. Wai, et al.. (2016). Three‐dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model. The Journal of Pathology. 240(3). 315–328. 31 indexed citations
7.
Wai, Patty T., Philip Bland, Saira Khalique, et al.. (2016). Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures. Journal of Visualized Experiments. 2 indexed citations
8.
Somaiah, Navita, John Yarnold, Frances Daley, et al.. (2012). The Relationship Between Homologous Recombination Repair and the Sensitivity of Human Epidermis to the Size of Daily Doses Over a 5-Week Course of Breast Radiotherapy. Clinical Cancer Research. 18(19). 5479–5488. 24 indexed citations
9.
Mandeville, Henry, Quan Sing Ng, Frances Daley, et al.. (2012). Operable Non–Small Cell Lung Cancer: Correlation of Volumetric Helical Dynamic Contrast-enhanced CT Parameters with Immunohistochemical Markers of Tumor Hypoxia. Radiology. 264(2). 581–589. 37 indexed citations
10.
Gaya, Andrew, Frances Daley, N. Jane Taylor, et al.. (2008). Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study. British Journal of Cancer. 99(2). 321–326. 22 indexed citations
11.
Koukourakis, Michael I., Søren M. Bentzen, Alexandra Giatromanolaki, et al.. (2006). Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and Neck Cancer Patients Recruited in the CHART Randomized Trial. Journal of Clinical Oncology. 24(5). 727–735. 225 indexed citations
12.
Wilson, George D., Michele I. Saunders, Stanley Dische, et al.. (2006). Pre-treatment proliferation and the outcome of conventional and accelerated radiotherapy. European Journal of Cancer. 42(3). 363–371. 13 indexed citations
13.
Beresford, Mark, et al.. (2006). The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer. British Journal of Cancer. 95(12). 1683–1688. 42 indexed citations
14.
Atkin, Gary, Frances Daley, Sarah Bourne, et al.. (2006). The impact of surgically induced ischaemia on protein levels in patients undergoing rectal cancer surgery. British Journal of Cancer. 95(7). 928–933. 12 indexed citations
15.
Pacifico, Marc D., Rajiv Grover, Paul Richman, et al.. (2005). Development of a Tissue Array for Primary Melanoma with Long-Term Follow-Up: Discovering Melanoma Cell Adhesion Molecule as an Important Prognostic Marker. Plastic & Reconstructive Surgery. 115(2). 367–375. 43 indexed citations
16.
Pacifico, Marc D., Rajiv Grover, Paul Richman, et al.. (2005). Identification of P-cadherin in Primary Melanoma Using a Tissue Microarrayer. Annals of Plastic Surgery. 55(3). 316–320. 8 indexed citations
17.
Burcombe, Russell, Andreas Makris, P I Richman, et al.. (2004). Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. British Journal of Cancer. 92(1). 147–155. 140 indexed citations
18.
Ataman, Ö., Søren M. Bentzen, George D. Wilson, et al.. (2004). Molecular biomarkers and site of first recurrence after radiotherapy for head and neck cancer. European Journal of Cancer. 40(18). 2734–2741. 20 indexed citations
19.
Wilson, George D., M.I. Saunders, Stanley Dische, et al.. (2001). bcl-2 expression in head and neck cancer: an enigmatic prognostic marker. International Journal of Radiation Oncology*Biology*Physics. 49(2). 435–441. 43 indexed citations
20.
Lotayef, Mohamed, George D. Wilson, Frances Daley, Hassan K. Awwad, & Tarek Shouman. (2000). Aberrant expression of cyclin A in head and neck cancer. British Journal of Cancer. 83(1). 30–34. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026